Latest Breaking News On - Biological sample - Page 9 : vimarsana.com

Russia sanctions: what next for Sputnik Covid-19 vaccine production?

Ukraine’s conflict has knock-on effects on the Covid-19 pandemic as supplies of Sputnik V vaccine to Asian, African, and South American countries now in question.

Black seaOceans generalUnited statesWorld health organizationAl qahirahGlobaldata pharmsourceKirill dmitrievPaul stronskiChris murphyCansino biologicsWilson centerDrug processing technologyCarnegie endowment for international peaceSample servicesRussian direct investment fundLaboratory equipment

4D pharma to begin Parkinson s disease trial with approval for applications

4D pharma to begin Parkinson s disease trial with approval for applications
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Lbps mrxAlex stevensonCentric services forElectronic data capture solutions for clinical trialsDrug administrationSample servicesPatient advisory boardUnited kingdomClinical supplyBiological sampleCentric servicesAlternate site clinical trialsData capture solutions

Arrowhead starts trial of complement-mediated disease therapeutic

Arrowhead Pharmaceuticals has dosed the first participants in Phase I/II trial of ARO-C3 to treat complement-mediated diseases.

James hamiltonArrowhead pharmaceuticalsLife sciences companiesSaas platform decentralizing clinical research at scaleSample servicesTranslation services forClinical supplyBiological sampleLife sciences

Resverlogix expands apabetalone s Phase IIb trial for Covid-19

Resverlogix has expanded the Phase IIb clinical trial for analysing apabetalone (RVX-208) as a potential oral Covid-19 therapy to Brazil.

Donald mccaffreyCentric services forWorld health organizationMonitoring solutions for clinicalHealth canadaSample servicesOrdinal scaleClinical improvementCentric servicesAlternate site clinical trialsClinical supplyBiological sampleReal time trackingMonitoring solutions

Kintor doses first subject in Phase III Covid-19 therapy trial in China

Kintor Pharmaceutical has dosed the first participant in China in its Phase III trial of proxalutamide to treat Covid-19 outpatients.

Kintor pharmaHongzhou luShanghai public health clinical centerChina national medical products administrationMonitoring solutions for clinicalSample servicesPublic health clinical centerKintor pharmaceuticalThird peopleBeijing ditan hospitalChina japan friendship hospitalFifth peopleHangzhou xixiTong youzhiCost effective preclinical cancer model searchesClinical supply